DW91170B
/ Dong Wha
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
DW91170B: A novel potent EZH1/2 dual inhibitor for adrenocortical carcinoma treatment
(AACR 2025)
- "In summary, the novel EZH1/2 inhibitor DW91170B exhibits anti-tumor efficacy in adrenocortical carcinoma. These effects appear to be mediated by alterations in cancer cell characteristics and the inhibition of cell survival."
Adrenal Cortex Carcinoma • Endocrine Cancer • Genito-urinary Cancer • Oncology • Solid Tumor • CYP11B1 • EZH2 • SMARCA4
1 to 1
Of
1
Go to page
1